Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review

Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review

Abstract Objective Bupropion, an antidepressant inhibiting the reuptake of dopamine and noradrenaline, should be useful to treat depressive symptoms in patients with Parkinson’s disease (PD). Limited and conflicting literature data questioned its effectiveness and safety in depressed PD patients and...

Full description

Bibliographic Details
Main Authors: Matteo Vismara, Beatrice Benatti, Gregorio Nicolini, Ilaria Cova, Edoardo Monfrini, Alessio Di Fonzo, Vincenza Fetoni, Caterina A. Viganò, Alberto Priori, Bernardo Dell’Osso
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Neurology
Subjects:
Bupropion
Parkinson’s disease
Depression
Neuropsychiatric symptoms
Pharmacological treatment
Online Access:https://doi.org/10.1186/s12883-022-02668-4

Similar Items

Similar Items